Cargando…
Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention
An acute exacerbation of chronic obstructive pulmonary disease (COPD) is sustained worsening of dyspnoea and sputum production in patients with COPD. They may be managed in the community with oral steroids and antibiotics but hospital referral is required where there is doubt about the diagnosis or...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108343/ https://www.ncbi.nlm.nih.gov/pubmed/32288564 http://dx.doi.org/10.1016/j.mpmed.2008.01.009 |
_version_ | 1783512792169447424 |
---|---|
author | Seemungal, Terence Wedzicha, Jadwiga A. |
author_facet | Seemungal, Terence Wedzicha, Jadwiga A. |
author_sort | Seemungal, Terence |
collection | PubMed |
description | An acute exacerbation of chronic obstructive pulmonary disease (COPD) is sustained worsening of dyspnoea and sputum production in patients with COPD. They may be managed in the community with oral steroids and antibiotics but hospital referral is required where there is doubt about the diagnosis or if there are features of severity such as confusion, respiratory distress or haemodynamic instability. Regular review is required as failure to improve should prompt consideration of another diagnosis. In the emergency department, nebulized β(2)–agonists and anticholinergic bronchodilators should be given and arterial blood gases assessed. Patients with an arterial pH of 7.35 or less should be assessed for non-invasive ventilation. Patients who are stable and are not in type 2 respiratory failure should be considered for discharge if there is adequate home support. Warded patients should be discharged if they are stable for 24 hours and if both patient and doctor are confident that they can manage at home with outpatient follow-up at 4 to 6 weeks. About 25% of COPD patients may not have recovered to baseline lung function at this time. |
format | Online Article Text |
id | pubmed-7108343 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71083432020-03-31 Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention Seemungal, Terence Wedzicha, Jadwiga A. Medicine (Abingdon) Article An acute exacerbation of chronic obstructive pulmonary disease (COPD) is sustained worsening of dyspnoea and sputum production in patients with COPD. They may be managed in the community with oral steroids and antibiotics but hospital referral is required where there is doubt about the diagnosis or if there are features of severity such as confusion, respiratory distress or haemodynamic instability. Regular review is required as failure to improve should prompt consideration of another diagnosis. In the emergency department, nebulized β(2)–agonists and anticholinergic bronchodilators should be given and arterial blood gases assessed. Patients with an arterial pH of 7.35 or less should be assessed for non-invasive ventilation. Patients who are stable and are not in type 2 respiratory failure should be considered for discharge if there is adequate home support. Warded patients should be discharged if they are stable for 24 hours and if both patient and doctor are confident that they can manage at home with outpatient follow-up at 4 to 6 weeks. About 25% of COPD patients may not have recovered to baseline lung function at this time. Elsevier Ltd. 2008-04 2008-04-04 /pmc/articles/PMC7108343/ /pubmed/32288564 http://dx.doi.org/10.1016/j.mpmed.2008.01.009 Text en Copyright © 2008 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Seemungal, Terence Wedzicha, Jadwiga A. Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention |
title | Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention |
title_full | Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention |
title_fullStr | Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention |
title_full_unstemmed | Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention |
title_short | Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention |
title_sort | acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108343/ https://www.ncbi.nlm.nih.gov/pubmed/32288564 http://dx.doi.org/10.1016/j.mpmed.2008.01.009 |
work_keys_str_mv | AT seemungalterence acuteexacerbationsofchronicobstructivepulmonarydiseasetreatmentandprevention AT wedzichajadwigaa acuteexacerbationsofchronicobstructivepulmonarydiseasetreatmentandprevention |